Trial Profile
Effect of Alemtuzumab in combination with Low Dose Radiation in patients with Sickle Cell Disease who underwent hematopoietic stem cell transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Apr 2015
Price :
$35
*
At a glance
- Drugs Alemtuzumab (Primary)
- Indications Sickle cell anaemia
- Focus Therapeutic Use
- 17 Apr 2015 New trial record